Hughes and Associates

02/04/2026

In today’s Clinical Pharmacology and Pharmacometrics hiring market, the biggest risk often isn’t hiring the wrong person, it’s never making a decision.

Across biopharma, we’re seeing senior CP/PMx searches slow down as teams aim for near-perfect fits. The intention makes sense: no one wants to miss.

But longer processes usually mean:

- more interview rounds
- more stakeholders
- more delays

When a role stays open too long, candidates start to read between the lines. They may wonder if the scope, budget, or internal alignment is still evolving.

In hybrid and hub-based markets, top CP and PMx leaders have options, and unclear or prolonged processes quietly push them away.

What tends to work better:
- clearly defining Day-1 essentials vs. Day-90 learnable
- setting a firm decision point
- prioritizing signal over volume in interviews

In a tight market, clarity and momentum are part of your employer brand.

01/28/2026

In this clip, we discuss why senior Clinical Pharmacology hiring requires precision upfront, and how clarity, not volume, ultimately drives better outcomes in complex drug development environments.

Full video podcast available on the Hughes and Associates YouTube page.

01/22/2026

Clinical Pharmacology leadership roles at the Director-to-Head level are taking longer to fill, and many quietly reset, despite strong candidate activity early in the process.

In our experience, this isn’t simply a market or timing issue. It reflects a deeper leadership calibration challenge, shaped by broader scope, cross-functional complexity, and a much narrower pool of senior leaders prepared to operate at this level.

This article shares a market perspective on what’s driving these hiring challenges across pharma and biotech, and why filling these roles correctly has become increasingly difficult.

The full article explores these dynamics in more detail:
https://www.haallc.com/2026/01/22/clinical-pharmacology-hiring-challenges/

Explore the clinical pharmacology leadership hiring challenges that delay filling key roles in pharma and biotech organizations.

01/16/2026

We’re grateful to ASCPT for hosting last year’s ASCPT Career Connect: Navigating the Evolving Landscape of Clinical Pharmacology, which brought together industry leaders to discuss how the function continues to evolve across drug development organizations.

This short excerpt features Jay Chapman, our SVP at Hughes and Associates, sharing perspective on leadership and cross-functional transition, an area we see increasingly shaping outcomes at the senior level. As Clinical Pharmacology leaders take on broader strategic influence, alignment across functions becomes just as critical as scientific depth.

This clip reflects only a small portion of a broader panel discussion.

At Hughes and Associates, we work closely with organizations navigating these leadership transitions and see firsthand how clarity around scope, influence, and cross-functional expectations impacts both hiring decisions and long-term success.

To access the full video of Jay’s discussion, please message us directly. The complete webinar and additional ASCPT Career Connect programming can be found on ASCPT’s website and social channels.

01/08/2026

At the senior level, more candidates rarely produce better outcomes.

Large slates create comparison fatigue. Decision-making slows. Strong candidates lose momentum while teams wait to see “one more profile.”

We see this most often in highly specialized leadership roles such as Clinical Pharmacology and Pharmacometrics, where surface fit can be easy to mistake for readiness.

The most effective searches begin with precision, a clear definition of what success in the role actually requires.

Volume doesn’t create confidence. Precision does.

12/30/2025

For many Clinical Pharmacology leaders, the holiday period brings quieter calendars and fewer meetings.

December isn’t a pause; it’s a planning window.

With fewer interruptions and lighter schedules, this time of year often creates the space for clearer thinking, more thoughtful discussions, and future-focused decisions that can be difficult to make during busier program cycles.

12/23/2025

Season’s Greetings from Hughes and Associates!

As we close the year, we look ahead to 2026 with focus and purpose. We’re grateful to the leaders, partners, and candidates who trusted us with critical hiring decisions across the pharmaceutical and biotechnology industries.

Wishing you a peaceful holiday season and a successful year ahead.

12/18/2025

The holidays are often viewed as a slow or impractical time to recruit.

In reality, December through early January can be one of the most effective windows to quietly secure hard-to-fill leadership and senior technical talent, particularly in Clinical Pharmacology, PK/PD (DMPK/PKPD), and MIDD, while the market is distracted and competition is paused.

In our latest blog, we share 5 Holiday Hiring Hacks biotech and pharmaceutical teams are using to get ahead of 2026 planning, without job postings, noise, or wasted time.

👉 Read the full article: https://www.haallc.com/2025/12/17/holiday-hiring-in-clinical-pharmacology/

If a quiet, confidential conversation would be helpful, feel free to message us.

Discover the advantages of holiday hiring in clinical pharmacology. Now is the perfect time to secure exceptional candidates.

12/12/2025

In today’s data-driven biotech landscape, competitive advantage comes from how well your quantitative teams are integrated.

Future-ready organizations align Clinical Pharmacology, Pharmacometrics, QSP, DMPK, and Bioanalysis, and empower scientists to influence decisions across development.

The result? Faster programs, clearer strategy, and reduced risk.

At Hughes & Associates, we partner with biotech and pharma companies to build high-impact quantitative science teams, one strategic hire at a time.

Let’s build the team your pipeline needs next.
📩jchapman@haallc.com
📞 704-264-5203

12/04/2025

🎙️ New Podcast Alert!
Give this a listen and stay ahead of the evolving 2025–2026 talent landscape in Modeling & Simulation.

Demand for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology talent is outpacing supply. As 2026 approaches, hybrid scientists and strong communicators will be among the most sought-after profiles in biopharma.

🔥 Key takeaways:
• Hybrid M&S scientists are becoming the gold standard
• Demand will continue to outpace supply in 2026
• Communication and cross-functional influence matter more than ever
• Market shifts are creating new mobility and career advantages

If you’re planning your next move or exploring the 2026 landscape, we can help you navigate the opportunities ahead.

👉 Ready to take the next step? Contact us directly at www.haallc.com

12/02/2025

Model-informed drug development is evolving fast, and for QSP, Pharmacometrics, DMPK, PBPK, and Clinical Pharmacology professionals, 2026 will be a pivotal year.

The industry is moving toward hybrid scientists who can bridge computation, biology, and strategic decision-making. With the demand accelerating faster than the talent pool, top modeling & simulation experts are entering 2026 with unprecedented leverage.

Our latest newsletter highlights:
✅ Why hybrid profiles are becoming the new standard
✅ How demand for M&S talent will outpace supply even further in 2026
✅ The rising importance of communication and cross-functional impact
✅ New mobility created by retention challenges
✅ How to position your CV and career direction now for 2025–2026

👉 If you're exploring new opportunities or simply assessing your market position, this is the moment to prepare.

At Hughes & Associates, we support professionals across biotech and pharma, helping them translate scientific impact into strategic career growth.

🔗 Read the full feature and plan your 2025–2026 career strategy: https://www.haallc.com/2025/11/27/career-opportunities-in-2025-2026-positioning-yourself-for-model-informed-roles/

Uncover the trends in Model-Informed Drug Development and the growing demand for modeling and simulation experts in biopharma.

11/19/2025

AI is accelerating change across life sciences in 2025, from personalized dosing to real-time modeling, advanced ADME predictions, and faster biomarker validation. These innovations are reshaping Clinical Pharmacology, Pharmacometrics, DMPK, QSP, and Bioanalysis, and driving demand for specialists who can integrate AI into scientific decision-making.

At Hughes and Associates, we help organizations find the cross-disciplinary experts who can bridge domain knowledge with AI-driven modeling and analysis.

💬Which AI-related skill is hardest for your team to hire for today?